 As part of his presentation, Dr. Paulini will provide a corporate overview and update on the Companys lead product, MacrilenTM macimorelin, the only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency AGHD. Dr. Paulinis slide presentation will be made available on the Companys website on Monday, February 17th. 